Revertant multiresistant HIV in chronically infected drug naïve patients: When baseline resistance testing is not enough

International Journal of STD and AIDS

Volumn 18, Issue 10, 2007, Pages 722-724

  Baraboutis, Ioannis G ^a   Papastamopoulos, Vassilios ^a   Georgiou, Ourania ^a   Skoutelis, Athanasios T ^a  

^a EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Antiretroviral therapy; Chronic HIV infection; Genotypic resistance testing; Multiresistant HIV; Revertant variant

Indexed keywords

EFAVIRENZ; EMTRICITABINE; EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LOPINAVIR PLUS RITONAVIR; SAQUINAVIR; TENOFOVIR; ANTIVIRUS AGENT;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; COMBINATION CHEMOTHERAPY; DNA POLYMORPHISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GENE MUTATION; GENETIC RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT FAILURE; VIRUS LOAD; VIRUS STRAIN; VIRUS TRANSMISSION; AMINO ACID SUBSTITUTION; ANTIVIRAL RESISTANCE; CODON; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIOLOGICAL EXAMINATION; VIROLOGY;

ADULT; AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; CODON; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; VIRAL LOAD;

EID: 38449118329     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/095646207782193830     Document Type: Article

References (13)

1. Cane PA. Stability of transmitted drug-resistant HIV-1 species. Curr Opin Infect Dis 2005;18:537-42
2. Shet A, Berry LBS, Mohri H, et al. Tracking the prevalence of transmitted antiretroviral drug resistant HIV-1. A decade of experience. J Acquir Immune Defic Syndr 2006;41:439-46
3. Garcia R, Cianchetta M, Paravissini A. Increase in prevalence of primary mutations in naïve HIV patients in Spain. Fifth European HIV Drug Resistance Workshop, Cascais, Portugal, 28-30 March 2007. Abstract No. 6, abstract book 6
4. Palma AC, Araujo F, Duque V, Borges F, Paixao MT, Camacho R. Trends of resistance transmission in newly diagnosed patients in Portugal over time. Fifth European HIV Drug Resistance Workshop, Cascais, Portugal, 28-30 March 2007. Abstract No. 21, abstract book 14
5. Novak RM, Chen L, Mac Arthur RD, et al. Prevalence of antiretroviral drug resistance mutations in chronically HIV-infected, treatment-naive patients: implications for routine resistance screening before initiation of antiretroviral therapy. Clin Infect Dis 2005;40:468-74
6. Gandhi RT, Wurcel A, Rosenberg ES, et al. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis 2003;37:1693-8
7. Fox J, Dustan S, McClure M, Weber J, Fidler S. Transmitted drug-resistant HIV-1 in primary HIV-1 infection; incidence, evolution and impact on response to antiretroviral therapy. HIV Med 2006;7:477-83
8. Little SJ, Holte S, Routy JP, et al. Antiretroviral-drug resistance among patients recently infected with HIV. N Engl J Med 2002;347:385-94
9. Oette M, Kaiser R, Däumer M, et al. Primary HIV drug resistance and efficacy of first-line antiretroviral therapy guided by resistance testing. J Acquir Immune Defic Syndr 2006;41:573-81
10. Oette M, Kaiser R, Däumer M, et al. First-line HAART guided by genotypic resistance testing: Beware of revertant variants. Fifth European HIV Drug Resistance Workshop, Cascais, Portugal, 28-30 March 2007. Abstract No. 96, abstract book 76
11. Van Laethem K, De Munter P, Schrooten Y, et al. No response to first-line tenofovir+lamivudine+efavirenz despite optimization according to baseline resistance testing: impact of resistant minority variants on efficacy of low genetic barrier drugs. J Clin Virol 2007;39:43-7 [Epub], [doi: 10.1016/j.jcv.2007.02.003]
12. Bruzzone B, Setti M, Villa R, De Florentis D, Icardi G. Multidrug resistance transmission confirms the need of virus sequencing before treating both acute and chronic naive HIV patients. Fifth European HIV Drug Resistance Workshop, Cascais, Portugal, 28-30 March 2007. Abstract No. 122, abstract book 98-9
13. Ghosn J, Pellegrin I, Goujard C, et al. HIV-1 resistant strains acquired at the time of primary infection massively fuel the cellular reservoir and persist for lengthy periods of time. AIDS 2006;20:159-70